OPKO Health, Inc. Sales Revenue, Services, Net (Deprecated 2018-01-31)
OPKO Health, Inc. (OPK) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $211.31 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2019-01-29
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $211.31M, a 7.54% decline year-over-year.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $41.72M, a 72.37% decline year-over-year.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $229.03M, a 11.58% decline year-over-year.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $256.67M, a 3.51% decline year-over-year.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $8.67M, a 25.66% decline from fiscal 2013.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2013 was $11.66M, a 566.55% increase from fiscal 2012.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2012 was $1.75M, a 1195.56% increase from fiscal 2011.
- OPKO Health, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2011 was $135.00K.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-03-31 | $211.31M 10-Q · filed 2018-05-08 | $253.03M derived: sum of 2 quarters · filed 2019-01-29 | $482.07M derived: sum of 3 quarters · filed 2019-01-29 | $738.74M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-12-31 | $41.72M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $270.75M derived: sum of 2 quarters · filed 2019-01-29 | $527.42M derived: sum of 3 quarters · filed 2019-01-29 | $782.71M 8-K · filed 2019-01-29 | $889.08M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $229.03M 10-Q · filed 2017-11-08 | $485.71M derived: sum of 2 quarters · filed 2017-11-08 | $740.99M 10-Q · filed 2017-11-08 | $865.26M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-06-30 | $256.67M 10-Q · filed 2017-08-08 | $511.96M 10-Q · filed 2017-08-08 | $636.23M derived: sum of 3 quarters · filed 2019-01-29 | $895.25M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-03-31 | $228.54M 10-Q · filed 2018-05-08 | $255.29M 10-Q · filed 2017-05-10 | $379.56M derived: sum of 2 quarters · filed 2019-01-29 | $638.58M derived: sum of 3 quarters · filed 2019-01-29 | $904.60M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-12-31 | $151.01M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $410.04M derived: sum of 2 quarters · filed 2019-01-29 | $676.05M derived: sum of 3 quarters · filed 2019-01-29 | $928.57M 8-K · filed 2019-01-29 | $1.01B 10-K · filed 2017-03-01 | |
| 2016-09-30 | $259.02M 10-Q · filed 2017-11-08 | $525.04M derived: sum of 2 quarters · filed 2017-11-08 | $777.56M 10-Q · filed 2017-11-08 | $974.93M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-06-30 | $266.01M 10-Q · filed 2017-08-08 | $518.53M 10-Q · filed 2017-08-08 | $715.91M derived: sum of 3 quarters · filed 2019-01-29 | $819.83M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-03-31 | $252.52M 10-Q · filed 2017-05-10 | $449.89M derived: sum of 2 quarters · filed 2019-01-29 | $553.81M derived: sum of 3 quarters · filed 2019-01-29 | $555.72M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2015-12-31 | $197.37M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $301.29M derived: sum of 2 quarters · filed 2019-01-29 | $303.20M derived: sum of 3 quarters · filed 2019-01-29 | $305.30M 8-K · filed 2019-01-29 | $329.74M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $103.92M 10-Q · filed 2016-11-07 | $105.83M derived: sum of 2 quarters · filed 2016-11-07 | $107.93M 10-Q · filed 2016-11-07 | $109.96M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $1.91M 10-Q · filed 2016-08-08 | $3.98M 10-Q · filed 2016-08-08 | $6.04M derived: sum of 3 quarters · filed 2017-03-01 | $8.52M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $2.07M 10-Q · filed 2016-05-09 | $4.13M derived: sum of 2 quarters · filed 2017-03-01 | $6.61M derived: sum of 3 quarters · filed 2017-03-01 | $8.76M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.54M derived: sum of 2 quarters · filed 2017-03-01 | $6.70M derived: sum of 3 quarters · filed 2017-03-01 | $8.67M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $2.48M 10-Q · filed 2015-11-09 | $4.63M derived: sum of 2 quarters · filed 2015-11-09 | $6.61M 10-Q · filed 2015-11-09 | $9.21M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $2.15M 10-Q · filed 2015-08-05 | $4.12M 10-Q · filed 2015-08-05 | $6.73M derived: sum of 3 quarters · filed 2016-02-29 | $9.50M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $1.97M 10-Q · filed 2015-05-11 | $4.58M derived: sum of 2 quarters · filed 2016-02-29 | $7.35M derived: sum of 3 quarters · filed 2016-02-29 | $10.54M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.38M derived: sum of 2 quarters · filed 2016-02-29 | $8.57M derived: sum of 3 quarters · filed 2016-02-29 | $11.66M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $2.77M 10-Q · filed 2014-11-07 | $5.96M derived: sum of 2 quarters · filed 2014-11-07 | $9.05M 10-Q · filed 2014-11-07 | $10.47M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $3.19M 10-Q · filed 2014-08-11 | $6.28M 10-Q · filed 2014-08-11 | $7.70M derived: sum of 3 quarters · filed 2015-02-27 | $7.80M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $3.09M 10-Q · filed 2014-05-09 | $4.51M derived: sum of 2 quarters · filed 2015-02-27 | $4.61M derived: sum of 3 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.52M derived: sum of 2 quarters · filed 2015-02-27 | $1.75M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $100.00K 10-Q · filed 2013-11-12 | $332.00K 10-Q · filed 2013-11-12 | ||||
| 2011-12-31 | $135.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |